1-methyl-1,2,3,4-tetrahydroisoquinoline and ketamine

1-methyl-1,2,3,4-tetrahydroisoquinoline has been researched along with ketamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Antkiewicz-Michaluk, L; Białoń, M; Wąsik, A; Żarnowska, M	1

Other Studies

1 other study(ies) available for 1-methyl-1,2,3,4-tetrahydroisoquinoline and ketamine

Article	Year
Comparison of the effects of 1MeTIQ and olanzapine on performance in the elevated plus maze test and monoamine metabolism in the brain after ketamine treatment. Pharmacology, biochemistry, and behavior, 2019, Volume: 181 Topics: Analysis of Variance; Animals; Antipsychotic Agents; Anxiety; Behavior, Animal; Brain; Dopamine; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Ketamine; Locomotion; Male; Maze Learning; Monoamine Oxidase Inhibitors; Norepinephrine; Olanzapine; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Serotonin; Tetrahydroisoquinolines	2019

Article

Year

Comparison of the effects of 1MeTIQ and olanzapine on performance in the elevated plus maze test and monoamine metabolism in the brain after ketamine treatment.

Pharmacology, biochemistry, and behavior, 2019, Volume: 181

Topics: Analysis of Variance; Animals; Antipsychotic Agents; Anxiety; Behavior, Animal; Brain; Dopamine; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Ketamine; Locomotion; Male; Maze Learning; Monoamine Oxidase Inhibitors; Norepinephrine; Olanzapine; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Serotonin; Tetrahydroisoquinolines

2019